SlideShare a Scribd company logo
1 of 30
 Designing around
patent system
1
/30
www.PharmInfopedia.com
2
/30
Costs incurred by the participants in the patent
system
Opposing objectives
Designing around patent
Fiesto decision and effects
Design around patent- From perspective of competitor
Design around patent- From perspective of patent
holder
www.PharmInfopedia.com
Costs to patentee:
R&D costs
Delayed first sale or disclosure
Cost of compliance with patent rules and
laws (application fees)
Legal fees
Potential enforcement/defense costs
(litigation)
3
/30
www.PharmInfopedia.com
Costs to society:
Higher prices for consumers
Discourages further research in areas
newly patented
4
/30
www.PharmInfopedia.com
Provides notice to society
Chilling effect on competition
5
/30
www.PharmInfopedia.com
Patentee seeks to develop broad patent
protection that:
maximizes the opportunity to charge
for
monopoly costs; and
minimizes the likelihood of a successful
design around.
6
/30
www.PharmInfopedia.com
Non-patentee seeks to create a
competitive
product:
not burdened with the monopoly costs
of the
patentee;
that maximizes the likelihood of a
finding of
noninfringement (or invalidity); and
7
/30
www.PharmInfopedia.com
Bypass much of the R&D costs
Capture market share
8
/30
www.PharmInfopedia.com
Intentional “designing around” of the patent claims is
not by
itself a wrong which must be compensated by
invocation of
the doctrine of equivalents. Designing around patents
is, in
fact, one of the ways in which the patent system works
to the
advantage of the public in promoting progress in the
useful
art, its constitutional purpose…
9
/30
www.PharmInfopedia.com
Often at the junction of prosecution
history
estoppel and the doctrine of
equivalents.
10
/30
www.PharmInfopedia.com
If a claim element was narrowed by
amendment, and the claim amendment
was
made for a reason related to
patentability,
then there can be no infringement of that
claim under the doctrine of equivalents.
11
/30
www.PharmInfopedia.com
Provides a recipe for designing around for a
competitor.
Provides greater challenges for patent
applicants
in preventing design around efforts.
12
/30
www.PharmInfopedia.com
Simplified designing around strategy in
light of Festo
read the prosecution history to identify
amendments made for patentability
reasons;
13
/30
www.PharmInfopedia.com
Conservative design around strategies
A) Select a solution from the prior art (if
enforceable patent, then obtain a license,
acquire rights)
or
B) Develop an alternative solution based on a
problem-oriented approach and obtain a
competent non-infringement opinion.
14
/30
www.PharmInfopedia.com
Alternative design around strategy
(prior to Festo and possibly if Festo overturned)
a) focus on the broadest valid claim (identified
based on
review of prior art and prosecution history)
b) substitute an element
i) one that performs substantially same function in a
substantially different way
ii) identified by prosecution history estoppel
c) obtain a competent non-infringement opinion
d) adjust practice based on Supreme Court
ruling in Festo.
15
/30
www.PharmInfopedia.com
Draft applications with eye towards Festo - example
strategies:
A) file with narrower claims to avoid amending during
prosecution
B) use one-sided range criteria (avoid double ended
ranges)
C) format claims for clear demarcation between
elements
D) when forced to amend, add a new element rather than
amend an existing element
E) conduct a reasonably thorough art search before filing
F) appeal rather than amend
16
/30
www.PharmInfopedia.com
- No missing element possibilities.
- No unnecessary estoppel.
- No alternative methods/functions to
get to same outcome.
17
/30
www.PharmInfopedia.com
 File a Strong and Comprehensive Specification
 Do a Thorough Prior Art Search and Draft Accordingly
 Be Careful with Amendment Arguments and Claim
Changes
18
/30
www.PharmInfopedia.com
Claim Differences from Prior Art, not
Embodiments
Find and Claim THE Invention not Embodiments
Embodiment = What the inventor is using or has
made
Invention = All combinations of pieces of the
embodiment
that overcome the prior art, claim the differences
19
/30
www.PharmInfopedia.com
20
/30
Differences:
- sloped tail fin - wheels 2-1 versus 1-2 - faster
- bent nosecone - wing attach point - tail powered
- jets, not props - hold more cargo - wing attach
- many wheels on - higher ceiling - new material
www.PharmInfopedia.com
Capture all the Ground
you
can that is not Prior Art
21
/30
Capture the “Invention Territory”
www.PharmInfopedia.com
Diversify Claims to Cover Invention Territory
22
/30
www.PharmInfopedia.com
23
/30
www.PharmInfopedia.com
24
/30
Avoid Unnecessary Claim Limitations
www.PharmInfopedia.com
Stretch the Invention, Do Advanced Inventing
25
/30
www.PharmInfopedia.com
Approach Claims From Different Angles
An integrated circuit comprising:
 a first conductive layer;
 a second conductive layer overlying the first
conductive layer;
 an original via located between the first and second
conductive layers;
 a first overlay layer of the file structure defining a two-
dimensional layout of a first conductive layer;
 a second overlay layer of the file structure defining a
two-dimensional layout of a plurality of vias;
26
/30
www.PharmInfopedia.com
Make Sure Claim Limitations are
Detectable
Levels of detectability:
simple inspection of
product/literature
non-detectable
27
/30
www.PharmInfopedia.com
 Write note on Festo decision and effect. (2 marks)
 Define design around. (2 marks)
 Note on opposing objectives of patentee and
competitor. (2 marks)
 Note on Design around patent -from the perspective
of competitor (5 marks)
 Note on Design around patent- From the
perspective
of patentee (5 marks)
28
/30
www.PharmInfopedia.com
 http://www.mit-forum.co.il/2006events/idea/guy_yonay.pdf
 http://conferences.utcle.org/law/cle/conferences/archive/PT05/0
1.3_Witek_PT05_ses01_revppt.pdf
 http://www.foley.com/files/tbl_s31Publications/FileUpload137/18
79/nanotechexplosion.pdf
 http://www.uil-
sipo.si/Seminar_licenciranje06/Rating_Valuation.pdf
 http://www.uil-
sipo.si/Seminar_licenciranje06/Commercial_use.pdf
 http://www.intproplaw.com/articles/PatentProcess.pdf
 http://www.law.unimelb.edu.au/ipria/events/Rubinfeld
%20Powerpoint%20Presentation.ppt#1
29
/30
www.PharmInfopedia.com
30www.PharmInfopedia.com

More Related Content

Viewers also liked

BOOLEAN COMBINATION AND TRIZ CRITERIA A PRACTICAL APPLICATION OF A PATENT-C...
BOOLEAN COMBINATION AND TRIZ CRITERIA   A PRACTICAL APPLICATION OF A PATENT-C...BOOLEAN COMBINATION AND TRIZ CRITERIA   A PRACTICAL APPLICATION OF A PATENT-C...
BOOLEAN COMBINATION AND TRIZ CRITERIA A PRACTICAL APPLICATION OF A PATENT-C...
Roberto Nani
 
TRIZ (теория решения изобретательских задач) - Very Powerful Methodology for ...
TRIZ (теория решения изобретательских задач) - Very Powerful Methodology for ...TRIZ (теория решения изобретательских задач) - Very Powerful Methodology for ...
TRIZ (теория решения изобретательских задач) - Very Powerful Methodology for ...
Nozir Shokirov
 

Viewers also liked (8)

BOOLEAN COMBINATION AND TRIZ CRITERIA A PRACTICAL APPLICATION OF A PATENT-C...
BOOLEAN COMBINATION AND TRIZ CRITERIA   A PRACTICAL APPLICATION OF A PATENT-C...BOOLEAN COMBINATION AND TRIZ CRITERIA   A PRACTICAL APPLICATION OF A PATENT-C...
BOOLEAN COMBINATION AND TRIZ CRITERIA A PRACTICAL APPLICATION OF A PATENT-C...
 
Richards 1st TRIZ Patent
Richards 1st TRIZ PatentRichards 1st TRIZ Patent
Richards 1st TRIZ Patent
 
Triz- Presentation
Triz- PresentationTriz- Presentation
Triz- Presentation
 
Systematic Innovation An Introduction To Triz
Systematic Innovation    An Introduction To TrizSystematic Innovation    An Introduction To Triz
Systematic Innovation An Introduction To Triz
 
TRIZ (теория решения изобретательских задач) - Very Powerful Methodology for ...
TRIZ (теория решения изобретательских задач) - Very Powerful Methodology for ...TRIZ (теория решения изобретательских задач) - Very Powerful Methodology for ...
TRIZ (теория решения изобретательских задач) - Very Powerful Methodology for ...
 
Workbook Advanced Patent Analysis Using TRIZ and Other Techniques
Workbook Advanced Patent Analysis Using TRIZ and Other TechniquesWorkbook Advanced Patent Analysis Using TRIZ and Other Techniques
Workbook Advanced Patent Analysis Using TRIZ and Other Techniques
 
Introduction To TRIZ
Introduction To TRIZIntroduction To TRIZ
Introduction To TRIZ
 
TRIZ overview and examples
TRIZ overview and examplesTRIZ overview and examples
TRIZ overview and examples
 

Similar to Designing around patent

SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009
SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009
SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009
SterneKessler
 
AIPJ_25.4_June2015_hoad&polites
AIPJ_25.4_June2015_hoad&politesAIPJ_25.4_June2015_hoad&polites
AIPJ_25.4_June2015_hoad&polites
Richard Hoad
 
Presentation_Costa Rica 2014
Presentation_Costa Rica 2014Presentation_Costa Rica 2014
Presentation_Costa Rica 2014
Daniel Santos
 
Intellectual property rights (2)
Intellectual property rights (2)Intellectual property rights (2)
Intellectual property rights (2)
Nits Kedia
 

Similar to Designing around patent (20)

Hitting the Licensing Bullseye: The Business Aspects of Patents
Hitting the Licensing Bullseye:  The Business Aspects of PatentsHitting the Licensing Bullseye:  The Business Aspects of Patents
Hitting the Licensing Bullseye: The Business Aspects of Patents
 
Claiming Strategies for Medical Device Patent Application PLUS - Bonus Update...
Claiming Strategies for Medical Device Patent Application PLUS - Bonus Update...Claiming Strategies for Medical Device Patent Application PLUS - Bonus Update...
Claiming Strategies for Medical Device Patent Application PLUS - Bonus Update...
 
Types of patents
Types of patentsTypes of patents
Types of patents
 
Patent Law in 2014: Act fast or get left behind
Patent Law in 2014: Act fast or get left behindPatent Law in 2014: Act fast or get left behind
Patent Law in 2014: Act fast or get left behind
 
03-Brief Overview of U.S. Utility Patent Law and Practice
03-Brief Overview of U.S. Utility Patent Law and Practice03-Brief Overview of U.S. Utility Patent Law and Practice
03-Brief Overview of U.S. Utility Patent Law and Practice
 
SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009
SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009
SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009
 
Patent Law Update
Patent Law UpdatePatent Law Update
Patent Law Update
 
typesofpatents-111011053928-phpapp02.ppt
typesofpatents-111011053928-phpapp02.ppttypesofpatents-111011053928-phpapp02.ppt
typesofpatents-111011053928-phpapp02.ppt
 
Introduction-to-Surrender-of-Patent.pptx
Introduction-to-Surrender-of-Patent.pptxIntroduction-to-Surrender-of-Patent.pptx
Introduction-to-Surrender-of-Patent.pptx
 
Patent presentation
Patent presentationPatent presentation
Patent presentation
 
Licensing SEPs: When are License Terms Fair, Reasonable and Non-Discriminatory?
Licensing SEPs: When are License Terms Fair, Reasonable and Non-Discriminatory?Licensing SEPs: When are License Terms Fair, Reasonable and Non-Discriminatory?
Licensing SEPs: When are License Terms Fair, Reasonable and Non-Discriminatory?
 
Patent/IP for Enterpreneur
Patent/IP for EnterpreneurPatent/IP for Enterpreneur
Patent/IP for Enterpreneur
 
SANY PPT 1.pptx
SANY PPT 1.pptxSANY PPT 1.pptx
SANY PPT 1.pptx
 
Georgetown Univ. Law Center Conference: Post-Grant Patent Proceedings: Are th...
Georgetown Univ. Law Center Conference: Post-Grant Patent Proceedings: Are th...Georgetown Univ. Law Center Conference: Post-Grant Patent Proceedings: Are th...
Georgetown Univ. Law Center Conference: Post-Grant Patent Proceedings: Are th...
 
AIPJ_25.4_June2015_hoad&polites
AIPJ_25.4_June2015_hoad&politesAIPJ_25.4_June2015_hoad&polites
AIPJ_25.4_June2015_hoad&polites
 
New Patent System
New Patent SystemNew Patent System
New Patent System
 
A Primer on Patent Rights, Singularity & Infropy
A Primer on Patent Rights, Singularity & InfropyA Primer on Patent Rights, Singularity & Infropy
A Primer on Patent Rights, Singularity & Infropy
 
Presentation_Costa Rica 2014
Presentation_Costa Rica 2014Presentation_Costa Rica 2014
Presentation_Costa Rica 2014
 
What is IP, Patents in Pharma Industry
What is IP, Patents in Pharma IndustryWhat is IP, Patents in Pharma Industry
What is IP, Patents in Pharma Industry
 
Intellectual property rights (2)
Intellectual property rights (2)Intellectual property rights (2)
Intellectual property rights (2)
 

More from Gaurav Kr

Clinical trails
Clinical trailsClinical trails
Clinical trails
Gaurav Kr
 
Clinical study and gcp
Clinical study and gcpClinical study and gcp
Clinical study and gcp
Gaurav Kr
 
Clinical research
Clinical researchClinical research
Clinical research
Gaurav Kr
 

More from Gaurav Kr (20)

Instrumental analysis
Instrumental analysisInstrumental analysis
Instrumental analysis
 
Investigational new drug application
Investigational new drug applicationInvestigational new drug application
Investigational new drug application
 
Fractional factorial design tutorial
Fractional factorial design tutorialFractional factorial design tutorial
Fractional factorial design tutorial
 
Herbals
HerbalsHerbals
Herbals
 
Herbal medicine
Herbal medicineHerbal medicine
Herbal medicine
 
Investigational new drug application
Investigational new drug applicationInvestigational new drug application
Investigational new drug application
 
Gmp for water for p'cal use
Gmp for water for p'cal useGmp for water for p'cal use
Gmp for water for p'cal use
 
Gmp compliance
Gmp complianceGmp compliance
Gmp compliance
 
GMP and cGMP
GMP and cGMPGMP and cGMP
GMP and cGMP
 
Foi and iig
Foi and iigFoi and iig
Foi and iig
 
Drug master files
Drug master filesDrug master files
Drug master files
 
Drug development and nda
Drug development and ndaDrug development and nda
Drug development and nda
 
EMEA
EMEAEMEA
EMEA
 
Dosage form design
Dosage form designDosage form design
Dosage form design
 
Control of microbial growth
Control of microbial growthControl of microbial growth
Control of microbial growth
 
Computer system validation
Computer system validationComputer system validation
Computer system validation
 
Clinical trails
Clinical trailsClinical trails
Clinical trails
 
Clinical study and gcp
Clinical study and gcpClinical study and gcp
Clinical study and gcp
 
Clinical research
Clinical researchClinical research
Clinical research
 
Cder
CderCder
Cder
 

Recently uploaded

會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
中 央社
 

Recently uploaded (20)

philosophy and it's principles based on the life
philosophy and it's principles based on the lifephilosophy and it's principles based on the life
philosophy and it's principles based on the life
 
ANTI PARKISON DRUGS.pptx
ANTI         PARKISON          DRUGS.pptxANTI         PARKISON          DRUGS.pptx
ANTI PARKISON DRUGS.pptx
 
Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45
Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45
Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45
 
Mattingly "AI and Prompt Design: LLMs with Text Classification and Open Source"
Mattingly "AI and Prompt Design: LLMs with Text Classification and Open Source"Mattingly "AI and Prompt Design: LLMs with Text Classification and Open Source"
Mattingly "AI and Prompt Design: LLMs with Text Classification and Open Source"
 
An overview of the various scriptures in Hinduism
An overview of the various scriptures in HinduismAn overview of the various scriptures in Hinduism
An overview of the various scriptures in Hinduism
 
REPRODUCTIVE TOXICITY STUDIE OF MALE AND FEMALEpptx
REPRODUCTIVE TOXICITY  STUDIE OF MALE AND FEMALEpptxREPRODUCTIVE TOXICITY  STUDIE OF MALE AND FEMALEpptx
REPRODUCTIVE TOXICITY STUDIE OF MALE AND FEMALEpptx
 
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
 
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General QuizPragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
 
IPL Online Quiz by Pragya; Question Set.
IPL Online Quiz by Pragya; Question Set.IPL Online Quiz by Pragya; Question Set.
IPL Online Quiz by Pragya; Question Set.
 
Features of Video Calls in the Discuss Module in Odoo 17
Features of Video Calls in the Discuss Module in Odoo 17Features of Video Calls in the Discuss Module in Odoo 17
Features of Video Calls in the Discuss Module in Odoo 17
 
How to Manage Closest Location in Odoo 17 Inventory
How to Manage Closest Location in Odoo 17 InventoryHow to Manage Closest Location in Odoo 17 Inventory
How to Manage Closest Location in Odoo 17 Inventory
 
An Overview of the Odoo 17 Knowledge App
An Overview of the Odoo 17 Knowledge AppAn Overview of the Odoo 17 Knowledge App
An Overview of the Odoo 17 Knowledge App
 
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
 
Dementia (Alzheimer & vasular dementia).
Dementia (Alzheimer & vasular dementia).Dementia (Alzheimer & vasular dementia).
Dementia (Alzheimer & vasular dementia).
 
size separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceuticssize separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceutics
 
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT VẬT LÝ 2024 - TỪ CÁC TRƯỜNG, TRƯ...
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT VẬT LÝ 2024 - TỪ CÁC TRƯỜNG, TRƯ...TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT VẬT LÝ 2024 - TỪ CÁC TRƯỜNG, TRƯ...
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT VẬT LÝ 2024 - TỪ CÁC TRƯỜNG, TRƯ...
 
An Overview of the Odoo 17 Discuss App.pptx
An Overview of the Odoo 17 Discuss App.pptxAn Overview of the Odoo 17 Discuss App.pptx
An Overview of the Odoo 17 Discuss App.pptx
 
Removal Strategy _ FEFO _ Working with Perishable Products in Odoo 17
Removal Strategy _ FEFO _ Working with Perishable Products in Odoo 17Removal Strategy _ FEFO _ Working with Perishable Products in Odoo 17
Removal Strategy _ FEFO _ Working with Perishable Products in Odoo 17
 
Basic Civil Engineering notes on Transportation Engineering, Modes of Transpo...
Basic Civil Engineering notes on Transportation Engineering, Modes of Transpo...Basic Civil Engineering notes on Transportation Engineering, Modes of Transpo...
Basic Civil Engineering notes on Transportation Engineering, Modes of Transpo...
 
Graduate Outcomes Presentation Slides - English (v3).pptx
Graduate Outcomes Presentation Slides - English (v3).pptxGraduate Outcomes Presentation Slides - English (v3).pptx
Graduate Outcomes Presentation Slides - English (v3).pptx
 

Designing around patent

  • 1.  Designing around patent system 1 /30 www.PharmInfopedia.com
  • 2. 2 /30 Costs incurred by the participants in the patent system Opposing objectives Designing around patent Fiesto decision and effects Design around patent- From perspective of competitor Design around patent- From perspective of patent holder www.PharmInfopedia.com
  • 3. Costs to patentee: R&D costs Delayed first sale or disclosure Cost of compliance with patent rules and laws (application fees) Legal fees Potential enforcement/defense costs (litigation) 3 /30 www.PharmInfopedia.com
  • 4. Costs to society: Higher prices for consumers Discourages further research in areas newly patented 4 /30 www.PharmInfopedia.com
  • 5. Provides notice to society Chilling effect on competition 5 /30 www.PharmInfopedia.com
  • 6. Patentee seeks to develop broad patent protection that: maximizes the opportunity to charge for monopoly costs; and minimizes the likelihood of a successful design around. 6 /30 www.PharmInfopedia.com
  • 7. Non-patentee seeks to create a competitive product: not burdened with the monopoly costs of the patentee; that maximizes the likelihood of a finding of noninfringement (or invalidity); and 7 /30 www.PharmInfopedia.com
  • 8. Bypass much of the R&D costs Capture market share 8 /30 www.PharmInfopedia.com
  • 9. Intentional “designing around” of the patent claims is not by itself a wrong which must be compensated by invocation of the doctrine of equivalents. Designing around patents is, in fact, one of the ways in which the patent system works to the advantage of the public in promoting progress in the useful art, its constitutional purpose… 9 /30 www.PharmInfopedia.com
  • 10. Often at the junction of prosecution history estoppel and the doctrine of equivalents. 10 /30 www.PharmInfopedia.com
  • 11. If a claim element was narrowed by amendment, and the claim amendment was made for a reason related to patentability, then there can be no infringement of that claim under the doctrine of equivalents. 11 /30 www.PharmInfopedia.com
  • 12. Provides a recipe for designing around for a competitor. Provides greater challenges for patent applicants in preventing design around efforts. 12 /30 www.PharmInfopedia.com
  • 13. Simplified designing around strategy in light of Festo read the prosecution history to identify amendments made for patentability reasons; 13 /30 www.PharmInfopedia.com
  • 14. Conservative design around strategies A) Select a solution from the prior art (if enforceable patent, then obtain a license, acquire rights) or B) Develop an alternative solution based on a problem-oriented approach and obtain a competent non-infringement opinion. 14 /30 www.PharmInfopedia.com
  • 15. Alternative design around strategy (prior to Festo and possibly if Festo overturned) a) focus on the broadest valid claim (identified based on review of prior art and prosecution history) b) substitute an element i) one that performs substantially same function in a substantially different way ii) identified by prosecution history estoppel c) obtain a competent non-infringement opinion d) adjust practice based on Supreme Court ruling in Festo. 15 /30 www.PharmInfopedia.com
  • 16. Draft applications with eye towards Festo - example strategies: A) file with narrower claims to avoid amending during prosecution B) use one-sided range criteria (avoid double ended ranges) C) format claims for clear demarcation between elements D) when forced to amend, add a new element rather than amend an existing element E) conduct a reasonably thorough art search before filing F) appeal rather than amend 16 /30 www.PharmInfopedia.com
  • 17. - No missing element possibilities. - No unnecessary estoppel. - No alternative methods/functions to get to same outcome. 17 /30 www.PharmInfopedia.com
  • 18.  File a Strong and Comprehensive Specification  Do a Thorough Prior Art Search and Draft Accordingly  Be Careful with Amendment Arguments and Claim Changes 18 /30 www.PharmInfopedia.com
  • 19. Claim Differences from Prior Art, not Embodiments Find and Claim THE Invention not Embodiments Embodiment = What the inventor is using or has made Invention = All combinations of pieces of the embodiment that overcome the prior art, claim the differences 19 /30 www.PharmInfopedia.com
  • 20. 20 /30 Differences: - sloped tail fin - wheels 2-1 versus 1-2 - faster - bent nosecone - wing attach point - tail powered - jets, not props - hold more cargo - wing attach - many wheels on - higher ceiling - new material www.PharmInfopedia.com
  • 21. Capture all the Ground you can that is not Prior Art 21 /30 Capture the “Invention Territory” www.PharmInfopedia.com
  • 22. Diversify Claims to Cover Invention Territory 22 /30 www.PharmInfopedia.com
  • 24. 24 /30 Avoid Unnecessary Claim Limitations www.PharmInfopedia.com
  • 25. Stretch the Invention, Do Advanced Inventing 25 /30 www.PharmInfopedia.com
  • 26. Approach Claims From Different Angles An integrated circuit comprising:  a first conductive layer;  a second conductive layer overlying the first conductive layer;  an original via located between the first and second conductive layers;  a first overlay layer of the file structure defining a two- dimensional layout of a first conductive layer;  a second overlay layer of the file structure defining a two-dimensional layout of a plurality of vias; 26 /30 www.PharmInfopedia.com
  • 27. Make Sure Claim Limitations are Detectable Levels of detectability: simple inspection of product/literature non-detectable 27 /30 www.PharmInfopedia.com
  • 28.  Write note on Festo decision and effect. (2 marks)  Define design around. (2 marks)  Note on opposing objectives of patentee and competitor. (2 marks)  Note on Design around patent -from the perspective of competitor (5 marks)  Note on Design around patent- From the perspective of patentee (5 marks) 28 /30 www.PharmInfopedia.com
  • 29.  http://www.mit-forum.co.il/2006events/idea/guy_yonay.pdf  http://conferences.utcle.org/law/cle/conferences/archive/PT05/0 1.3_Witek_PT05_ses01_revppt.pdf  http://www.foley.com/files/tbl_s31Publications/FileUpload137/18 79/nanotechexplosion.pdf  http://www.uil- sipo.si/Seminar_licenciranje06/Rating_Valuation.pdf  http://www.uil- sipo.si/Seminar_licenciranje06/Commercial_use.pdf  http://www.intproplaw.com/articles/PatentProcess.pdf  http://www.law.unimelb.edu.au/ipria/events/Rubinfeld %20Powerpoint%20Presentation.ppt#1 29 /30 www.PharmInfopedia.com